StockNews.com Begins Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC)
StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a report published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Price Performance Shares of Cyclacel Pharmaceuticals stock opened at $2.00 on Friday. The firm has a market cap of $25.92 million, a P/E ratio […]
StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a report published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Price Performance Shares of Cyclacel Pharmaceuticals stock opened at $2.00 on Friday. The firm has a market cap of $25.92 million, a P/E ratio […]
